One for the "UPS"
RNVO 55.75 - 56.25p
REASON : Fallen last week by 60% after phase II Juvista met its primary endpoint in a scar revision trial but missed the endpoint in a breast augmentation trial. Shire has place a lot of money into those trials so if share price does not improve a bid could be a solution